Home  »  News   »  Charting the Course: Pfizer Inc.’s PFE Stock...

Charting the Course: Pfizer Inc.’s PFE Stock Prospects

Pfizer Inc. (PFE) currently has a stock price of $33.64. The stock saw a sharp increase in the last trading session, hitting a high of $34.12 after opening at $34.12. The lowest recorded price for the day was $33.44 before it closed at $34.07.

The stock market performance of Pfizer Inc. has been fairly unsteady. Over the last year, the company’s stock hit its highest at $54.93 on 12/14/22, while the lowest price during the same time frame was $33.54, recorded on 09/18/23.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


52-week price history of PFE Stock

Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Pfizer Inc.’s current trading price is -38.76% away from its 52-week high, while its distance from the 52-week low is 0.30%. The stock’s price range for this period has remained between $33.54 and $54.93. The Healthcare sector company’s shares managed to surpass a trading volume of around 25.2 million for the day, which was noticeably higher compared to the shares’ average daily volume of 25.04 million over the last three months.

Financial Performance and Market Capitalization

Pfizer Inc. (PFE) has experienced a quarterly decline of -16.03% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 190.38B and boasts a workforce of 83000 employees.

Analysts’ Ratings For Pfizer Inc.

As of right now, 10 analysts are rating Pfizer Inc. as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 15 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.

Moving average and trading volume data

Based on Barchart.com data, the company’s moving average over the 100-day period was 36.91, with a change in price of -5.69. Similarly, Pfizer Inc. recorded 25,870,590 in trading volume during the last 100 days, posting a change of -14.47%.

PFE Debt-to-equity ratio analysis

The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PFE stands at 0.66. Similarly, the long-term debt-to-equity ratio is also 0.62.

PFE Stock Stochastic Average

As of today, the raw stochastic average of Pfizer Inc. over the last 50 days is at 4.59%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 5.34%. Further, the company’s Stochastic %K and %D values for the last 20 days were 12.20% and 14.55%, respectively.

PFE Stock Price Performance Analysis

Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. Year to date metric has recorded a loss of -34.35%.However, over the last six months, we can see a stronger performance of -16.11%. Over the last 30 days, the price of PFE has leaped by -7.86%. And in the last five days, it has fallen by -0.88%.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts